SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Klaus Stohr, Global Head of Influenza Franchises at Novartis to Give Plenary Keynote at the Infectious Diseases World Summit 2013

GTCbio
30 Apr 2013
Sarah Thomas
Associate Editor

Product news

Klaus Stohr, Vice President and Global Head of Influenza Franchises at Novartis, will give a keynote presentation titled "Global Trends in Pandemic Preparedness: Changes After the Last Pandemic?" at GTC's Infectious Diseases World Summit 2013 on July 8-10, 2013 in Boston, MA. Dr. Stohr's presentation will discuss efforts to accelerate pandemic vaccine investment and their need to acknowledge that it is mainly driven from two sources: political commitment to preparedness/public health or opportunities available from seasonal influenza vaccine use/manufacturing.

The Infectious Diseases World Summit 2013 will bring together experts from industry, academia, and the public sector to discuss cutting edge research and new technologies used in the pharmaceutical and biotech fields. It will also give global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant infectious diseases issues and deals that will affect the industry.

Featured speakers include Kathrin Jansen, Senior Vice President of Vaccine Research East & Early Development at Pfizer, Nathalie Garcon, Vice President and Head of the Global Adjuvant Center for Vaccines at GSK, Derek O'Hagan, Vice President and Global Head of Vaccine Delivery and Formulation Research at Novartis V&D, Jaap Goudsmit, Founder and Chief Scientist at the Crucell Vaccine Institute and Janssen Center of Excellence for Immunoprophylaxis, Robin Robinson, Director of Biomedical Advanced Research and Development Authority (BARDA) at the U.S. Department of Health & Human Services

Registration to the Infectious Diseases World Summit 2013 gives access to the 3 concurrent tracks:

. 11th Vaccines Research & Development: All Things Considered
. 2nd Influenza Research and Development
. 10th Anti-Infectives Partnering and Deal-making

Links

GTCbioCompany website

Tags

MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.InfluenzaVaccine DevelopmentVaccine development focuses on creating immunizations to protect against infectious diseases. The process involves identifying antigens, developing and testing vaccine efficacy, and ensuring safety through preclinical testing and multiple clinical trial phases. Scientists use various approaches, including weakened or inactivated viruses, protein subunits, or mRNA. Advanced platforms and rapid diagnostic tools aid in vaccine research and testing. Explore vaccine development solutions in our peer-reviewed product directory; compare products, read reviews, and get pricing directly from manufacturers. Infectious DiseasesInfectious diseases are caused by pathogens such as bacteria, viruses, and fungi. Effective detection, prevention, and treatment are crucial to control outbreaks and improve public health. Diagnostic tools, vaccines, and antimicrobial treatments are essential components of managing these diseases. Research into emerging pathogens and resistance patterns continues to evolve. Browse our peer-reviewed product directory to find the best diagnostic tools, prevention solutions, and treatment options; compare products, read customer reviews, and get pricing directly from manufacturers.

Related articles

Klaus Stohr, Global Head of Influenza Franchises at Novartis to Give Plenary Keynote at the Infectious Diseases World Summit 2013